<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7657A812-BA6C-4896-9696-9E3392BC4F6E"><gtr:id>7657A812-BA6C-4896-9696-9E3392BC4F6E</gtr:id><gtr:name>The Leverhulme Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4E777F7E-8B7E-406A-87FB-39A7026F891F"><gtr:id>4E777F7E-8B7E-406A-87FB-39A7026F891F</gtr:id><gtr:name>Uppsala University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/11E604AE-3915-4673-AEA6-852F7D6BFFD8"><gtr:id>11E604AE-3915-4673-AEA6-852F7D6BFFD8</gtr:id><gtr:name>Wellcome Trust</gtr:name><gtr:address><gtr:line1>183 EUSTON ROAD</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>NW1  2BE</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850"><gtr:id>5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850</gtr:id><gtr:name>University of Strathclyde</gtr:name><gtr:address><gtr:line1>16 Richmond Street</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G1 1XQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3D617999-511F-41CB-9373-828F3FCE9755"><gtr:id>3D617999-511F-41CB-9373-828F3FCE9755</gtr:id><gtr:name>Orla Protein Technnologies</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Materials</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7657A812-BA6C-4896-9696-9E3392BC4F6E"><gtr:id>7657A812-BA6C-4896-9696-9E3392BC4F6E</gtr:id><gtr:name>The Leverhulme Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4E777F7E-8B7E-406A-87FB-39A7026F891F"><gtr:id>4E777F7E-8B7E-406A-87FB-39A7026F891F</gtr:id><gtr:name>Uppsala University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/11E604AE-3915-4673-AEA6-852F7D6BFFD8"><gtr:id>11E604AE-3915-4673-AEA6-852F7D6BFFD8</gtr:id><gtr:name>Wellcome Trust</gtr:name><gtr:address><gtr:line1>183 EUSTON ROAD</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>NW1  2BE</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850"><gtr:id>5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850</gtr:id><gtr:name>University of Strathclyde</gtr:name><gtr:address><gtr:line1>16 Richmond Street</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G1 1XQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3D617999-511F-41CB-9373-828F3FCE9755"><gtr:id>3D617999-511F-41CB-9373-828F3FCE9755</gtr:id><gtr:name>Orla Protein Technnologies</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/9BF779E1-024E-4032-B1D3-435ED621406A"><gtr:id>9BF779E1-024E-4032-B1D3-435ED621406A</gtr:id><gtr:firstName>Catherine</gtr:firstName><gtr:otherNames>Louise</gtr:otherNames><gtr:surname>Merry</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0701165"><gtr:id>CAD3CAE8-ABE6-49B3-A3E4-1ABEBAC09429</gtr:id><gtr:title>Investigating and manipulating the changing display of glycosaminoglycan epitopes during ES cell differentiation</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0701165</gtr:grantReference><gtr:abstractText>All of the cells which make up the tissues of the body (e.g. the skin, liver, brain and blood) are surrounded by a layer of sugars which coat the cells. This sugar-coating is different for different cell types so, for example, a skin cell will have a type of sugar coat which is not the same as that of a liver cell. The sugars help the cells to know what type of cell they are and to respond to the other cells which surround them as well as to the chemical messages that pass between cells. Glycosaminoglycans are a special type of sugar which are part of the cell coat and also fill in the spaces between cells within tissues. This family of sugars have many unique properties which include the ability to prevent blood clotting (heparin), to enable joints to move freely (chondroitin sulphate) and to allow eggs to mature during the female reproductive cycle (hyaluronan). At present, the way in which cells make these sugars is not well understood. From the little we do know, we believe that isolated fragments of these sugars could be used to instruct cells to behave in particular ways, or that we might be able to force cells to make one particular type of sugar and not another, thereby influencing the way in which that cell grows and interacts with other cells. In this research plan, we will use embryonic stem (ES) cells to help understand how different cells make different sugar types and to test out our theories as to how sugars can influence cell behaviour. We have chosen ES cells for two main reasons. These cells are unusual in that they can be grown easily in the lab and can change from being one cell type (an ES cell) to another (e.g. a nerve cell). This will help us to understand how the sugars made by the cells change during this process. An additional benefit of using ES cells is that our research might suggest how sugars can be used to help ES cells grow in the lab or how they can be instructed to become cell types which could be of use in human therapies e.g. nerve cells, heart muscle cells or blood cells. Although cells made from ES cells are still a considerable time away from being used in people, research such as ours helps move towards this goal.</gtr:abstractText><gtr:technicalSummary>Glycosaminoglycans (GAGs) are essential cofactors for many of the signalling molecules which regulate embryonic stem (ES) cell pluripotency and differentiation. Whereas many groups are investigating the protein components of these signalling complexes, the carbohydrate fraction is less well understood and therefore remains an under-appreciated factor in the design of fully-defined ES cell culture systems or methods to direct differentiation. This project aims to extend our current limited knowledge of the function of specific GAG epitopes in mouse and human ES cells, and to use this information to manipulate ES cell differentiation. Recent evidence suggests that increasing sulphation within GAGs displayed on ES cells during early differentiation is essential for their efficient response to signalling factors. A panel of phage display-derived ScFv antibodies, previously used to detail specific patterns within heparan sulphate (HS) chains in mouse ES cells, will be expanded to include a study of human ES cell differentiation as well as to include ScFvs which recognise chondroitin and dermatan sulphate (CS/DS) epitopes. Focusing on neural differentiation, epitopes within GAG chains found to be implicated in the ability of the ES cells to respond to pro-differentiation signals will be targeted to directly assess the role of GAG biosynthetic enzymes and isolated GAG oligosaccharides in influencing cell behaviour.</gtr:technicalSummary><gtr:fund><gtr:end>2011-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>332274</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Materials Manchester</gtr:department><gtr:description>BIOSCENT</gtr:description><gtr:id>0C20EBED-7FD3-48B0-8586-3EC63E2758AB</gtr:id><gtr:impact>EU FP7 grant awarded in 2009. The collaboration is interdisciplinary involving clinicians, basic scientists and biomaterials engineers.</gtr:impact><gtr:outcomeId>kKuMUdPq4Mh-1</gtr:outcomeId><gtr:partnerContribution>This collaboration provides us with access to a large international grouping of researchers and clinicians. The group include cardiac surgeons, basic scientists, biomaterials engineers and compliance experts focused on developing novel functionalised biomaterials for cardiovascular repair.</gtr:partnerContribution><gtr:piContribution>We provide expertise in glycosaminoglycans which are used to functionalise hydrogels to optimise cell response.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Dundee</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Oncology and Molecular Medicine</gtr:department><gtr:description>Marios</gtr:description><gtr:id>308B0F9F-8D12-4A3E-8674-C92B4894AAC4</gtr:id><gtr:impact>We have co-published papers with Dr Stavridis.</gtr:impact><gtr:outcomeId>gCBYq2Gw1Zq-1</gtr:outcomeId><gtr:partnerContribution>Dr Stavridis has been a long-standing collaborative partner. This collaboration provides us with expertise in the signalling pathways underlying stem cell differentiation.</gtr:partnerContribution><gtr:piContribution>We provide expertise in glycosaminoglycans and how these sugars interact with signalling factors to influence stem cell behaviour.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Materials Manchester</gtr:department><gtr:description>Leverhulme</gtr:description><gtr:id>6CB98EB0-E4F7-4139-9FD3-351E7FFCA3D8</gtr:id><gtr:impact>We received funding from the Leverhulme Trust to support this collaboration, the project will start in Jan 2011. This project is interdisciplinary linking chemists with tissue engineers and stem cell biologists.</gtr:impact><gtr:outcomeId>jrcehAtf5tX-1</gtr:outcomeId><gtr:partnerContribution>This collaboration includes a tissue engineer in Manchester and a biomaterials chemist in Glasgow. We are working to better understand the role of mechanotransduction in regulating stem cell behaviour using novel engineered nano-patterned surfaces.</gtr:partnerContribution><gtr:piContribution>We are providing stem cell expertise and our knowledge of stem cell-matrix interactions. The experince we have gained from working with other biomaterials is also useful for this collaboration.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Dentistry Manchester</gtr:department><gtr:description>Ward</gtr:description><gtr:id>6BB13F23-0791-4137-81FD-1290FB3D439E</gtr:id><gtr:impact>I co-supervise a number of PhD and Masters level students with Dr Ward and we have co-published a number of research papers and reviews. We also collaborate on the EPSRC stem cell fractionation project.</gtr:impact><gtr:outcomeId>JXtMuNtWTqF-1</gtr:outcomeId><gtr:partnerContribution>Collaboration with Dr Ward's group enables us to explore various aspects of stem cell biology. In particular, we have collaborated on investigating the role of cell-cell interactions. Dr Ward's group also provide technical expertise in human ES cell culture.</gtr:partnerContribution><gtr:piContribution>We provide knowledge of cell-matrix interactions and how these might interact with cell-cell interactions in influencing stem cell behaviour.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Engineering and Physical Sciences</gtr:department><gtr:description>Stem Cell Fractionation</gtr:description><gtr:id>77C79AB6-8EB9-4A20-86F0-51988A250F7B</gtr:id><gtr:impact>We received a research grant from EPSRC to fund this collaboration. The project started in September 2010. The project is multi-disciplinary including engineers, life sceintists and materials scientists.</gtr:impact><gtr:outcomeId>gGvAZyayJsA-1</gtr:outcomeId><gtr:partnerContribution>This collaborative group includes experts in microfluidic technologies, matrix biology and stem cells. The group are working to develop a novel technology for the fractionation of stem cell populations based on their adhesion to matrix motifs. This is a novel application for our research.</gtr:partnerContribution><gtr:piContribution>We provide knowledge of the cell-matrix interface and of potenital motifs which may be used to selectively bind specific cell types.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Wellcome Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Wellcome Trust Centre for Cell-Matrix Research</gtr:department><gtr:description>Investigating the vascular progenitor cell niche</gtr:description><gtr:id>DF890AE9-5326-4307-BD76-5D59C740548C</gtr:id><gtr:impact>We were awarded an MRC grant to support this work (G0902170 MRC-BHF Cell-matrix biology of the vascular progenitor cell niche.) which will start in Jan 2011. This collaboration is multi-disciplinary with clinicians, life scientists and bio-engineers working together on the project.</gtr:impact><gtr:outcomeId>hCPpJ4LBCEX-1</gtr:outcomeId><gtr:partnerContribution>This collaboration allows us to expand our investigations of the role of glycosaminoglycans in regulating stem cell behaviour to the adult stem cell niche. The collaborating team also include experts in animal models as well as clinicians ensuring that there is a high level of clinical relevance to the work.</gtr:partnerContribution><gtr:piContribution>We contribute expertise in glycosaminoglycan analysis. This includes the structural and functional assays we have developed during the period of the NIRG grant. We also contribute expertise in biomaterial design and testing.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Leverhulme Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Whitelock</gtr:description><gtr:id>1ABE9AA5-7AF0-4ABD-B9C4-2DEDDD1224A8</gtr:id><gtr:impact>The collaboration is multi-disciplinary, covering cell biology, biochemistry and materials science. Outputs so far are primary increased knowledge and reagent development.</gtr:impact><gtr:outcomeId>58c4c6704e9792.33025736-1</gtr:outcomeId><gtr:partnerContribution>While working with our group John is supporting multiple projects providing knowledge and reagents to investigate the extracellular matrix in natural and synthetic matrices.</gtr:partnerContribution><gtr:piContribution>I am hosting a visit by Prof. John Whitelock. While working with our group John is learning how to carry out CRISPR modification of embryonic stem cell lines to model extracellular matrix related disease.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Strathclyde</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Pure and Applied Chemistry</gtr:department><gtr:description>HFSP</gtr:description><gtr:id>4EEEB03C-58D9-40FE-9AD6-10CC763154B9</gtr:id><gtr:impact>We reveived funding from the Human Frontiers Scientific Programme to support this collaboration. I have also co-supervised a PhD student working on a project related to this programme with Prof. Ulijn.</gtr:impact><gtr:outcomeId>Vsu1xHKH97o-1</gtr:outcomeId><gtr:partnerContribution>This collaboration is with two biomaterial chemists with outstanding international reputations. We are working to develop hydrogels which can be functionalised with glycosamionglycans to support and direct stem cell culture.</gtr:partnerContribution><gtr:piContribution>We bring our glycosaminoglycan and stem cell expertise to this collaboration. We also have experience of other hydrogel systems which is useful in improving hydrogel design.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Uppsala University</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Lena</gtr:description><gtr:id>41570C68-2966-45A2-B334-9643CAE96471</gtr:id><gtr:impact>We have co-published one paper to date. In 2014 I was awarded a Leverhulme Trust fellowship to spend a year in Sweden working with the Uppsala group. During this time we planned out a large EU consortium to apply a new approach to the study of rare disorders of GAG metabolism. We were unsuccesful with an EU H2020 project grant but recenlty resubmitted this as an MSCA ITN.</gtr:impact><gtr:outcomeId>56ddfd35928592.18692515-1</gtr:outcomeId><gtr:partnerContribution>The Uppsala group have world class expertise in glycosaminoglycan structural and functional characterisation as well as the use of animal models.</gtr:partnerContribution><gtr:piContribution>I have a long standing collaboration with this group. We have worked together to investigate the biosynthetic pathway of glycosaminoglycans. More recently, I have provided my expertise in biomaterials with which to mimic the extracellular matrix and in stem cell biology.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Orla Protein Technnologies</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Orla Protein Technologies</gtr:description><gtr:id>92F12D13-4953-4FD1-9149-D0BEAA6FB952</gtr:id><gtr:impact>We were awarded an EPSRC-funded knowledge-transfer award to fund this collaboration for six months this was worth ~ &amp;pound;75K, together with in-kind funding from the industrial partner. We are currently applying for a patent to cover the invention. This project is interdisciplinary, combining engineering (surface analysis), protein and sugar biochemistry and medicine (the target here are clinically relevant samples containig heparan sulphate.)</gtr:impact><gtr:outcomeId>qaoE5Cb9LL5-1</gtr:outcomeId><gtr:partnerContribution>Orla Protein Technologies are an SME which develop protein-based surfaces engineerd to express matrix-derived motifs. We have been working with Orla to optimise this system for the recognition of heparan sulphate and to display heparan sulphate-binding peptides.</gtr:partnerContribution><gtr:piContribution>We have worked with Orla as part of a 6 month knowledge transfer project to develop novel protein-based detection devices for heparan sulphate.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School Visit, Bury</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>9A151385-5361-40F7-9610-150CF38F34DC</gtr:id><gtr:impact>I visit this school every other year to talk about my career with A level students. The discussion is wide-ranging including my choice of research area, the role of women in science and career prospects in the current economic climate.

I have been contacted by students from the school and have provided them with information about summer placements etc.</gtr:impact><gtr:outcomeId>EoEmGsjnXCS</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to school children at the Museum of Science and Industry, Manchester (MOSI)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>35F371CB-CC24-4B9F-9762-D1C632DA8D2A</gtr:id><gtr:impact>I was one of two academics presenting 'Stem cell science' to a group of 14-16 year old school children as part of a discussion day organised by MOSI. The presentation was followed by a workshop where the children discussed the ethical implications of working with stem cells and the possible benefits for society.

We received good feedback from the students and the event is now scheduled to run every year.</gtr:impact><gtr:outcomeId>3B10E237AFB</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public lecture and discussion - Biochemical Determinants of Tissue Regeneration</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>41B7613C-9CE4-44D7-941F-DCD335CA33AA</gtr:id><gtr:impact>Lively dicussion and follow-up visits with local interest groups and schools.

We now have a good interaction with the local popular science interest groups and with the schools that participated in the event.</gtr:impact><gtr:outcomeId>546323bc198535.75108255</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to an American patient support group for Multiple Osteochondromas</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BF2AC3F0-2DAA-4608-8F31-4A84C6D3D54D</gtr:id><gtr:impact>I attended a meeting organised by the American patient support group for Multiple Osteochondromas. This disease is related to my research work and they were interested in how stem cell research could be used to find out more about the disease and possibly work towards developing therapeutics. I was interviewed and this will be displayed on the support group web site and will be used at support group information days.

None yet.</gtr:impact><gtr:outcomeId>F909D25567E</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC Radio Wales 'Science Cafe' Interview</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>92D95D59-5DFB-431B-8881-7D95BE3E9C6B</gtr:id><gtr:impact>We were interviewed by BBC Wales for their 'Science Cafe' - we talked about the hydrogel technology and how this could be used for tissue engineering or for toxicity screening.

BBC Radio Wales Interview

none so far</gtr:impact><gtr:outcomeId>r-8449812660.4126890cb61e9a</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Stem Cell Debate Day</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>2D1008C8-10F5-47B3-A5F7-340D051DD8B4</gtr:id><gtr:impact>The University of Manchester host Stem Cell Debate Days for A-Level students from local schools. I participate in these as an expert with experience of stem cells and tissue engineering. Each day hosts 30-50 students and we hold 3 or 4 a year. The students work through case-based scenarios and take part in facilitated debates.

We receive substantial positive feedback from the students on the day of the debate and have also had positive feedback from the teachers.</gtr:impact><gtr:outcomeId>fBscjsvFyQS</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009,2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>500000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>FP7</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>F9546196-446A-422C-B58E-D9506BDF1B39</gtr:id><gtr:outcomeId>gt6wuTiM6EZ0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>562650</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Grant/Human Frontiers Scientific Programme</gtr:description><gtr:end>2011-08-02</gtr:end><gtr:fundingOrg>Human Frontier Science Program (HFSP)</gtr:fundingOrg><gtr:id>AB8F045B-0B7F-4A3D-BE4D-F02BF4C04C73</gtr:id><gtr:outcomeId>pQomn3yHuyy0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>741792</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC/BHF joint Research Grant</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>124CB86F-71DA-477B-B7A6-4D00CE436076</gtr:id><gtr:outcomeId>KhX4HoTFS730</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>18720</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The Leverhulme Trust Visiting Professorship</gtr:description><gtr:end>2017-07-02</gtr:end><gtr:fundingOrg>The Leverhulme Trust</gtr:fundingOrg><gtr:fundingRef>VP-2016-014</gtr:fundingRef><gtr:id>038348A4-B5A8-4EE8-A315-8DB1EBE077E7</gtr:id><gtr:outcomeId>58c4ca365359b1.04044176</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>189360</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The Leverhulme Trust</gtr:description><gtr:end>2012-08-02</gtr:end><gtr:fundingOrg>The Leverhulme Trust</gtr:fundingOrg><gtr:id>C99A4E17-A621-4780-ACD2-BE2AAF78AE56</gtr:id><gtr:outcomeId>PEp2UkTkyK40</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2175436</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC EP/H046070/1 Stem cell fractionation using interactions with artificial matrices</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/H046070/1</gtr:fundingRef><gtr:id>F594FDF2-6D27-42C3-8F2D-A9D894AB27A8</gtr:id><gtr:outcomeId>BE9oJP22ybF0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC KTA</gtr:description><gtr:end>2012-08-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>20B010A6-D4E7-4046-B962-1C48FEBAE974</gtr:id><gtr:outcomeId>De9GtpUwAJQ0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>137000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Tools and Resorces Fund</gtr:description><gtr:end>2010-08-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>04DF2EA7-9038-4E8A-9B78-152AA3B6EA4B</gtr:id><gtr:outcomeId>rLzMXfarwwq0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>White paper</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>34491828-6E6A-4AE5-8E99-5485350D410B</gtr:id><gtr:outcomeId>56e0b6262b9d74.71019918</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type><gtr:url>http://ibcarb.com/wp-content/uploads/White-Paper-v7.pdf</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Participation in the International Proteoglycan Training Course</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>C03A0B8F-065D-4BC7-904F-59AD668869E6</gtr:id><gtr:outcomeId>npz4dUZ66aR</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>We are developing these reagents with Orla Protein Technologies. We were funded by an EPSRC KTA study and have continued the collaboration with the support of an EPSRC research grant.</gtr:description><gtr:id>B0C7BF48-25D3-48D2-A15F-6BD007D0136A</gtr:id><gtr:impact>The development is at too early a stage to give these details yet.</gtr:impact><gtr:outcomeId>ZALyGyhM2g3</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>heparan sulphate binding proteins</gtr:title><gtr:type>Support Tool - For Fundamental Research</gtr:type><gtr:yearDevCompleted>2011</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have completed our initial studies to define and characterise the role of heparan sulphate-type oligosaccharides in driving the formation of neural progenitor cells from embryonic stem cells. We have characterised the signalling pathways influenced by these oligosaccharides and can now start to apply these to human progenitor cell differentiation.</gtr:description><gtr:id>B777B23B-7581-4A2B-9480-530B62D96C73</gtr:id><gtr:impact>We are working with other groups to use these oligosaccharides to drive differentiation in multiple different progenitor cell assays. We are also working with other group developing biomaterial scaffolds on which to display these oligosaccharides.</gtr:impact><gtr:outcomeId>LivrbxurNSL</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>GAGs to drive differentiation of progenitor cells</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have developed methods to allow the combined analysis of cell-surface glycosaminoglycans using sensitive compositional analysis (fluroescent tagging and disaccharide analysis) and antibody-based analysis of the pattern-based carbohydrate epitopes displayed by the chains.</gtr:description><gtr:id>B90B3DB2-3B87-4AE1-883A-A71720F55EF5</gtr:id><gtr:impact>We have trained other groups in these techniques and provide on-going support for their analyses. We are often named as joint-authors on publications or acknowledged for our support. These analyses help significantly with defining the biological role of these complex sugars.</gtr:impact><gtr:outcomeId>o81pT8kk67n</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Combination of compositional and pattern-based glycosaminoglycan detection</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>2ABB9A59-14EA-42FE-B715-04BEE60A7138</gtr:id><gtr:title>The biochemical determinants of tissue regeneration.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/723d2b0b4df44ee7eeea5fff71a44b86"><gtr:id>723d2b0b4df44ee7eeea5fff71a44b86</gtr:id><gtr:otherNames>Giangreco A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>54632dba906df6.03035872</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2094D664-FB46-4DBC-A8D7-8E682A49B851</gtr:id><gtr:title>Using embryonic stem cells to understand how glycosaminoglycans regulate differentiation.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16f401a89cefc269cbb632c43d25c9bc"><gtr:id>16f401a89cefc269cbb632c43d25c9bc</gtr:id><gtr:otherNames>Holley RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>54632dba5ed510.27631417</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2A4AB9B-F724-4004-A60F-60FD66D5576E</gtr:id><gtr:title>Age-dependent changes in heparan sulfate in human Bruch's membrane: implications for age-related macular degeneration.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a7c80631b2c5d8d3651ac260b0e6e7f"><gtr:id>5a7c80631b2c5d8d3651ac260b0e6e7f</gtr:id><gtr:otherNames>Keenan TD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>54632db9e7f587.28886189</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F206EC0E-61B8-4B0D-B664-A552EA9F85B5</gtr:id><gtr:title>Mesenchymal stromal cells: inhibiting PDGF receptors or depleting fibronectin induces mesodermal progenitors with endothelial potential.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/594d70119813bf8fcf7296d601734a37"><gtr:id>594d70119813bf8fcf7296d601734a37</gtr:id><gtr:otherNames>Ball SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>54632dbb15de05.22858244</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>291C6F44-CD22-414F-9448-2E5A04C4A0D0</gtr:id><gtr:title>New strategies for cartilage regeneration exploiting selected glycosaminoglycans to enhance cell fate determination.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4fe7c81903a8dfd25582e8a4f68243c8"><gtr:id>4fe7c81903a8dfd25582e8a4f68243c8</gtr:id><gtr:otherNames>Ayerst BI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>54632dba3b3f42.68948498</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02CA5998-A696-4258-BA2E-433A35A0992C</gtr:id><gtr:title>Heparan sulfate inhibits hematopoietic stem and progenitor cell migration and engraftment in mucopolysaccharidosis I.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/904b19b2f1edd41f25aeec6846641b4a"><gtr:id>904b19b2f1edd41f25aeec6846641b4a</gtr:id><gtr:otherNames>Watson HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>54632db99dfae9.05242466</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>459BBC81-AA87-4D90-9CFE-7023FE21D714</gtr:id><gtr:title>Mucopolysaccharidosis type I, unique structure of accumulated heparan sulfate and increased N-sulfotransferase activity in mice lacking a-l-iduronidase.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16f401a89cefc269cbb632c43d25c9bc"><gtr:id>16f401a89cefc269cbb632c43d25c9bc</gtr:id><gtr:otherNames>Holley RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>54632dbb8e3837.45201059</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E43B3108-0D27-4D93-9DB8-0BD3746C52A4</gtr:id><gtr:title>Human serum-derived protein removes the need for coating in defined human pluripotent stem cell culture.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ff6bd6a400493e3f6da252cfcd71aa5"><gtr:id>3ff6bd6a400493e3f6da252cfcd71aa5</gtr:id><gtr:otherNames>Pijuan-Galit? S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>58c4c4f41dfbb2.89517683</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9143F782-FC69-45C2-92FB-2B602DEB58D0</gtr:id><gtr:title>Use of flow cytometry for characterization and fractionation of cell populations based on their expression of heparan sulfate epitopes.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16f401a89cefc269cbb632c43d25c9bc"><gtr:id>16f401a89cefc269cbb632c43d25c9bc</gtr:id><gtr:otherNames>Holley RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>54632db9c4f6f3.24615553</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E36DC923-CA98-42B4-BAA5-0191A03FEC4C</gtr:id><gtr:title>NDST2 (N-Deacetylase/N-Sulfotransferase-2) Enzyme Regulates Heparan Sulfate Chain Length.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7f961c4efd2c7e1eb0d306e21627471"><gtr:id>a7f961c4efd2c7e1eb0d306e21627471</gtr:id><gtr:otherNames>Deligny A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>58c4c4f4606827.44306552</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5AE280EE-8F2F-4CB8-8CA4-04051480C32D</gtr:id><gtr:title>Glycosaminoglycans as regulators of stem cell differentiation.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a19134a7de75b38d95e308674e4e2a9"><gtr:id>1a19134a7de75b38d95e308674e4e2a9</gtr:id><gtr:otherNames>Smith RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>BJipMJjFLgb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>170279C1-9818-4BF7-93B9-1B3EA83F4ED0</gtr:id><gtr:title>Novel cell lines isolated from mouse embryonic stem cells exhibiting de novo methylation of the E-cadherin promoter.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c64929b77237ad6dcfa3dadf2b85a4e6"><gtr:id>c64929b77237ad6dcfa3dadf2b85a4e6</gtr:id><gtr:otherNames>Hawkins K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>54632dba186df3.19965631</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7987D0DF-753C-4598-A357-1B97D9556B5D</gtr:id><gtr:title>Growth Differentiation Factor 5-Mediated Enhancement of Chondrocyte Phenotype Is Inhibited by Heparin: Implications for the Use of Heparin in the Clinic and in Tissue Engineering Applications.</gtr:title><gtr:parentPublicationTitle>Tissue engineering. Part A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4fe7c81903a8dfd25582e8a4f68243c8"><gtr:id>4fe7c81903a8dfd25582e8a4f68243c8</gtr:id><gtr:otherNames>Ayerst BI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1937-3341</gtr:issn><gtr:outcomeId>58c4c4f37799f6.59370053</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B38ABF49-C034-44B5-9861-D316D1281036</gtr:id><gtr:title>Immobilization of heparan sulfate on electrospun meshes to support embryonic stem cell culture and differentiation.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fdeb72ad89a0a76a148362f6a3f4865"><gtr:id>0fdeb72ad89a0a76a148362f6a3f4865</gtr:id><gtr:otherNames>Meade KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>54632dbb429de5.01978962</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD9DEE2C-A64C-4639-98E1-7A0FC11EC029</gtr:id><gtr:title>Influencing hematopoietic differentiation of mouse embryonic stem cells using soluble heparin and heparan sulfate saccharides.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16f401a89cefc269cbb632c43d25c9bc"><gtr:id>16f401a89cefc269cbb632c43d25c9bc</gtr:id><gtr:otherNames>Holley RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>JEM8En711sG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF4A6C6D-8DBC-400B-AC40-119F9E774BA4</gtr:id><gtr:title>Self-assembling peptide hydrogel for intervertebral disc tissue engineering.</gtr:title><gtr:parentPublicationTitle>Acta biomaterialia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77a6928e6dbab1bc333ab9c77677c060"><gtr:id>77a6928e6dbab1bc333ab9c77677c060</gtr:id><gtr:otherNames>Wan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1742-7061</gtr:issn><gtr:outcomeId>58c4c4f3c613d9.13857592</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CAE987EE-7FB6-4D32-9B37-2CE790746B0C</gtr:id><gtr:title>Specific glycosaminoglycans modulate neural specification of mouse embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ce250479de8fafd953801c2cb268bf6"><gtr:id>3ce250479de8fafd953801c2cb268bf6</gtr:id><gtr:otherNames>Pickford CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>UvtawFdSa8z</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE72E37B-1951-4119-B42A-CB1C5ACC9439</gtr:id><gtr:title>Epithelial-mesenchymal status influences how cells deposit fibrillin microfibrils.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/344afd4d14fca5b163c061a770580655"><gtr:id>344afd4d14fca5b163c061a770580655</gtr:id><gtr:otherNames>Baldwin AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>54632dbade6f43.27137807</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9CDB18E-E430-4E4E-98AF-4C9A49914BD9</gtr:id><gtr:title>E-cadherin and, in its absence, N-cadherin promotes Nanog expression in mouse embryonic stem cells via STAT3 phosphorylation.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c64929b77237ad6dcfa3dadf2b85a4e6"><gtr:id>c64929b77237ad6dcfa3dadf2b85a4e6</gtr:id><gtr:otherNames>Hawkins K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>54632dbb67d105.25121477</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0701165</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>